{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-016259","form_type":"8-K","ticker":"APYX","cik":"0000719135","company_name":"Apyx Medical Corp","filed_at":"2025-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.098500+00:00","generated_at":"2026-05-21T19:20:51.190077+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Apyx Medical receives FDA 510(k) clearance for AYON Body Contouring System","bullets":["AYON is the first FDA-cleared all-in-one platform combining fat removal, contouring, tissue contraction, and electrosurgery.","Initial clearance covers Renuvion for lax skin, ultrasound liposuction, electrocoagulation; power liposuction submission planned later in 2025.","Commercial launch with key opinion leader surgeons in critical geographies expected in second half of 2025.","Company highlights >15 million GLP-1 drug users as a growth driver for body contouring procedures."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-016259","json":"https://secwatch.observer/filing/0001437749-25-016259.json","markdown":"https://secwatch.observer/filing/0001437749-25-016259.md","text":"https://secwatch.observer/filing/0001437749-25-016259.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/719135/000143774925016259/0001437749-25-016259-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/719135/000143774925016259/apyx20250509_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T19:20:51.190077+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}